SCHEMBL7951865

SCHEMBL7951865

CC(C)(C)c1cc(/C=C(/C#N)S(=O)(=O)c2ccc(F)cc2F)cc(Br)c1O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IGF1R P08069 1/20 0.54
CISD1 Q9NZ45 1/20 0.54
EGFR P00533 5/20 0.48
KMT2A Q03164 6/20 0.41
LMNA P02545 4/20 0.41
ALDH1A1 P00352 4/20 0.41
MEN1 O00255 4/20 0.41
SMN1; SMN2 Q16637 4/20 0.41
HSD17B10 Q99714 4/20 0.41
CYP3A4 P08684 3/20 0.41
MAPT P10636 3/20 0.41
TSHR P16473 3/20 0.41
BLM P54132 3/20 0.41
HPGD P15428 3/20 0.41
ALOX15 P16050 3/20 0.41
RGS12 O14924 2/20 0.41
GMNN O75496 2/20 0.41
TP53 P04637 2/20 0.41
CYP1A2 P05177 2/20 0.41
CYP2C9 P11712 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7951862 1.00 IGF1R (0.54) IGF1RCISD1EGFRKMT2ALMNA
SCHEMBL7951867 1.00 IGF1R (0.54) IGF1RCISD1EGFRKMT2ALMNA
SCHEMBL7966709 0.92 KMT2A (0.49) IGF1RCISD1EGFRKMT2ALMNA
SCHEMBL7966712 0.92 KMT2A (0.49) IGF1RCISD1EGFRKMT2ALMNA
SCHEMBL7966706 0.92 KMT2A (0.49) IGF1RCISD1EGFRKMT2ALMNA
SCHEMBL7966704 0.87 IGF1R (0.56) IGF1RCISD1EGFRKMT2ALMNA
SCHEMBL7966701 0.87 IGF1R (0.56) IGF1RCISD1EGFRKMT2ALMNA
SCHEMBL7966703 0.87 IGF1R (0.56) IGF1RCISD1EGFRKMT2ALMNA
SCHEMBL7965134 0.84 KMT2A (0.46) IGF1RCISD1EGFRKMT2ALMNA
SCHEMBL7965142 0.84 KMT2A (0.46) IGF1RCISD1EGFRKMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5891917-A MODULATING TYROSINE SIGNAL TRANSDUCTION TO PREVENT AND TREAT CELL PROLIFERATIVE DISORDERS OR CELL DIFFERENTIATION DISORDERS ASSOCIATED WITH PARTICULAR TYROSINE KINASES BY INHIBITING ONE OR MORE ABNORMAL TYROSINE KINASE ACTIVITIES SUGEN, INC. (US) 1999-04-06 US claimed
US-6225346-B1 FOR THERAPY AND PROPHYLAXIS OF CELL PROLIFERATIVE DISORDERS OR CELL DIFFERENTIATION DISORDERS ASSOCIATED WITH PARTICULAR TYROSINE KINASES BY INHIBITING ONE OR MORE ABNORMAL TYROSINE KINASE ACTIVITIES SUGEN, INC. 2001-05-01 US disclosed
US-5935993-A TYROSINE KINASE INHIBITORS; TREATMENT OF CELL GROWTH, CELL DIFFERENTIATION DISORDERS SUGEN, INC. (US) 1999-08-10 US disclosed
US-5891917-A MODULATING TYROSINE SIGNAL TRANSDUCTION TO PREVENT AND TREAT CELL PROLIFERATIVE DISORDERS OR CELL DIFFERENTIATION DISORDERS ASSOCIATED WITH PARTICULAR TYROSINE KINASES BY INHIBITING ONE OR MORE ABNORMAL TYROSINE KINASE ACTIVITIES SUGEN, INC. (US) 1999-04-06 US disclosed